SCHEMBL3786201

SCHEMBL3786201

CC(=O)SOc1ccc(N)c(-c2ccccc2N)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
BRD4 O60885 2/20 0.38
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
MAPT P10636 3/20 0.35
LMNA P02545 2/20 0.35
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
HPGD P15428 1/20 0.34
GAA P10253 2/20 0.34
CFTR P13569 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NOS2 P35228 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5045614 0.91 ALDH1A1 (0.39) ALDH1A1L3MBTL1BRD4MEN1KMT2A
SCHEMBL3783387 0.87 BACE1 (0.44) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL3788301 0.83 ALDH1A1 (0.44) ALDH1A1L3MBTL1BRD4MAPTHSD17B10
SCHEMBL3787831 0.82 ALDH1A1 (0.41) ALDH1A1BRD4MEN1KMT2AMAPT
SCHEMBL3805098 0.82 CYP19A1 (0.37) LMNAMAPK1KDM4ESMN1; SMN2HDAC3
SCHEMBL3790351 0.81 BRD4 (0.36) ALDH1A1L3MBTL1BRD4MAPTKDM4E
SCHEMBL3786259 0.80 MAPT (0.49) ALDH1A1L3MBTL1MEN1KMT2AMAPT
SCHEMBL3794925 0.80 ALDH1A1 (0.43) ALDH1A1L3MBTL1BRD4MEN1KMT2A
SCHEMBL3786267 0.79 ALDH1A1 (0.37) ALDH1A1L3MBTL1BRD4MEN1KMT2A
SCHEMBL3791040 0.78 ALDH1A1 (0.42) ALDH1A1L3MBTL1BRD4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 ALDH1A1 4339/4885L3MBTL1 3838/4885BRD4 96/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.